Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
26.41
-0.47 (-1.75%)
Feb 11, 2026, 3:12 PM EST - Market open

Arcutis Biotherapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
3,2351,6303059011,0431,225
Market Cap Growth
93.96%434.82%-66.18%-13.58%-14.88%-
Enterprise Value
3,1061,5082836266811,039
Last Close Price
26.8813.933.2314.8020.7428.13
PS Ratio
10.698.305.11244.56--
PB Ratio
20.4510.353.444.303.504.53
P/TBV Ratio
22.3111.013.714.453.504.53
EV/Sales Ratio
9.777.674.75169.88--
Debt / Equity Ratio
0.720.702.320.970.260.02
Asset Turnover
0.790.570.150.01--
Inventory Turnover
1.751.380.48---
Quick Ratio
3.073.726.3811.0611.6112.61
Current Ratio
3.504.147.0811.5712.0912.96
Return on Equity (ROE)
-28.17%-113.76%-175.79%-122.80%-72.62%-72.93%
Return on Assets (ROA)
-5.91%-23.25%-38.12%-43.97%-36.55%-42.14%
Return on Capital Employed (ROCE)
-14.10%-47.90%-81.80%-73.30%-55.10%-49.60%
Earnings Yield
-1.39%-8.59%-85.99%-34.55%-19.78%-11.07%
FCF Yield
-1.04%-6.89%-81.18%-28.63%-16.84%-9.25%
Buyback Yield / Dilution
-11.93%-74.53%-25.94%-11.39%-38.52%-1835.11%
Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q